![\"Synodinou_resize\"](\"https:\/\/researchreproduction.gr\/site\/wp-content\/uploads\/2014\/09\/Synodinou_resize.jpg\")
<\/p>\n<\/p>\n
\u03a3\u03cd\u03bd\u03c4\u03bf\u03bc\u03bf \u0392\u03b9\u03bf\u03b3\u03c1\u03b1\u03c6\u03b9\u03ba\u03cc \u03a3\u03b7\u03bc\u03b5\u03af\u03c9\u03bc\u03b1<\/strong><\/p>\n I\u03c9\u03ac\u03bd\u03bd\u03b1-P\u03b1\u03c7\u03ae\u03bb Traeger-\u03a3\u03c5\u03bd\u03bf\u03b4\u03b9\u03bd\u03bf\u03cd (Joanne Rachel Traeger-Synodinos)<\/p>\n \u039a\u03b1\u03b8\u03b7\u03b3\u03ae\u03c4\u03c1\u03b9\u03b1 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2, \u0394\u03b9\u03b5\u03c5\u03b8\u03cd\u03bd\u03c4\u03c1\u03b9\u03b1 \u0395\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf\u03c5 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae \u03a3\u03c7\u03bf\u03bb\u03ae, \u03a4\u03a5\u039c\u03a0 <\/p>\n \u03a0\u03c1\u03bf\u03c3\u03c9\u03c0\u03b9\u03ba\u03ac \u03c3\u03c4\u03bf\u03b9\u03c7\u03b5\u03af\u03b1<\/strong> \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03b9\u03b1\u03ba\u03ae \u0395\u03ba\u03c0\u03b1\u03af\u03b4\u03b5\u03c5\u03c3\u03b7<\/strong> M\u03b5\u03c4\u03b5\u03ba\u03c0\u03b1\u03af\u03b4\u03b5\u03c5\u03c3\u03b7 \u03c3\u03c4\u03bf \u03b5\u03be\u03c9\u03c4\u03b5\u03c1\u03b9\u03ba\u03cc<\/strong> \u0398\u03ad\u03c3\u03b5\u03b9\u03c2 \u0395\u03c1\u03b3\u03b1\u03c3\u03af\u03b1\u03c2<\/strong> \u0394\u03b9\u03b4\u03b1\u03ba\u03c4\u03b9\u03ba\u03cc \u03ad\u03c1\u03b3\u03bf<\/strong> \u0394\u03b9\u03b1\u03c4\u03c1\u03b9\u03b2\u03ad\u03c2<\/strong> \u0395\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03b9\u03ba\u03cc \u0388\u03c1\u03b3\u03bf<\/strong> \u03a3\u03c5\u03b3\u03b3\u03c1\u03b1\u03c6\u03b9\u03ba\u03cc \u03ad\u03c1\u03b3\u03bf<\/strong> \u03a3\u03c5\u03bc\u03bc\u03b5\u03c4\u03bf\u03c7\u03ae \u03c3\u03b5 \u03c7\u03c1\u03b7\u03bc\u03b1\u03c4\u03bf\u03b4\u03bf\u03c4\u03bf\u03cd\u03bc\u03b5\u03bd\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03b9\u03ba\u03ac \u03c0\u03c1\u03bf\u03b3\u03c1\u03ac\u03bc\u03bc\u03b1\u03c4\u03b1<\/strong> \u03a4\u03b9\u03bc\u03b7\u03c4\u03b9\u03ba\u03ad\u03c2 \u0394\u03b9\u03b1\u03ba\u03c1\u03af\u03c3\u03b5\u03b9\u03c2<\/strong> \u0395\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03bf\u03bd\u03b9\u03ba\u03ad\u03c2 \u0395\u03c4\u03b1\u03b9\u03c1\u03af\u03b5\u03c2<\/strong> \u03a3\u03c5\u03bd\u03c4\u03b1\u03ba\u03c4\u03b9\u03ba\u03cc \u0388\u03c1\u03b3\u03bf<\/strong> \u03a3\u03c5\u03bc\u03bc\u03b5\u03c4\u03bf\u03c7\u03ae \u03c3\u03b5 \u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03bf\u03bd\u03b9\u03ba\u03ad\u03c2 \u03c3\u03c5\u03bd\u03b1\u03bd\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2<\/strong> \u039f\u03c1\u03b3\u03b1\u03bd\u03c9\u03c4\u03b9\u03ba\u03cc -\u0394\u03b9\u03bf\u03b9\u03ba\u03b7\u03c4\u03b9\u03ba\u03cc \u0388\u03c1\u03b3\u03bf<\/strong> <\/p>\n","protected":false},"excerpt":{"rendered":" \u03a3\u03cd\u03bd\u03c4\u03bf\u03bc\u03bf \u0392\u03b9\u03bf\u03b3\u03c1\u03b1\u03c6\u03b9\u03ba\u03cc \u03a3\u03b7\u03bc\u03b5\u03af\u03c9\u03bc\u03b1 I\u03c9\u03ac\u03bd\u03bd\u03b1-P\u03b1\u03c7\u03ae\u03bb Traeger-\u03a3\u03c5\u03bd\u03bf\u03b4\u03b9\u03bd\u03bf\u03cd (Joanne Rachel Traeger-Synodinos) \u039a\u03b1\u03b8\u03b7\u03b3\u03ae\u03c4\u03c1\u03b9\u03b1 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2, \u0394\u03b9\u03b5\u03c5\u03b8\u03cd\u03bd\u03c4\u03c1\u03b9\u03b1 \u0395\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf\u03c5 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae \u03a3\u03c7\u03bf\u03bb\u03ae, \u03a4\u03a5\u039c\u03a0 \u0395\u03b8\u03bd\u03b9\u03ba\u03bf\u03cd \u03ba\u03b1\u03b9 \u039a\u03b1\u03c0\u03bf\u03b4\u03b9\u03c3\u03c4\u03c1\u03b9\u03b1\u03ba\u03bf\u03cd \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03af\u03bf\u03c5 \u0391\u03b8\u03b7\u03bd\u03ce\u03bd<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[49],"class_list":["post-518","post","type-post","status-publish","format-standard","hentry","category-7","tag-joanne-rachel-traeger-"],"_links":{"self":[{"href":"https:\/\/researchreproduction.gr\/site\/index.php?rest_route=\/wp\/v2\/posts\/518","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/researchreproduction.gr\/site\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/researchreproduction.gr\/site\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/researchreproduction.gr\/site\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/researchreproduction.gr\/site\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=518"}],"version-history":[{"count":9,"href":"https:\/\/researchreproduction.gr\/site\/index.php?rest_route=\/wp\/v2\/posts\/518\/revisions"}],"predecessor-version":[{"id":3945,"href":"https:\/\/researchreproduction.gr\/site\/index.php?rest_route=\/wp\/v2\/posts\/518\/revisions\/3945"}],"wp:attachment":[{"href":"https:\/\/researchreproduction.gr\/site\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/researchreproduction.gr\/site\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/researchreproduction.gr\/site\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n\u0395\u03b8\u03bd\u03b9\u03ba\u03bf\u03cd \u03ba\u03b1\u03b9 \u039a\u03b1\u03c0\u03bf\u03b4\u03b9\u03c3\u03c4\u03c1\u03b9\u03b1\u03ba\u03bf\u03cd \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03af\u03bf\u03c5 \u0391\u03b8\u03b7\u03bd\u03ce\u03bd<\/p>\n
\n\u03a4\u039f\u03a0\u039f\u03a3 \u039a\u0391\u0399 XPON. \u0393\u0395\u039d\u039d\u0397\u03a3\u0397\u03a3: \u039b\u03bf\u03bd\u03b4\u03af\u03bd\u03bf, \u039c\u03b5\u03b3 \u0392\u03c1\u03b5\u03c4\/\u03bd\u03b9\u03b1, 1957
\n\u0394IEY\u0398YN\u03a3H EP\u0393A\u03a3IA\u03a3: E\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf I\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2 \u03a0\u03b1\u03bd\/\u03bc\u03af\u03bf\u03c5 A\u03b8\u03b7\u03bd\u03ce\u03bd, N\u03bf\u03c3\u03bf\u03ba\u03bf\u03bc\u03b5\u03af\u03bf \u03a0\u03b1\u03af\u03b4\u03c9\u03bd \u201cA\u03b3\u03af\u03b1 \u03a3\u03bf\u03c6\u03af\u03b1\u201d, A\u03b8\u03ae\u03bd\u03b1, 11527
\nT\u03b7\u03bb.\/FAX: 210 746 7468\/ 210 779 5553<\/p>\n
\n1975-1978: \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03ae\u03bc\u03b9\u03bf \u03c4\u03bf\u03c5 Reading (University of Reading), \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03bf \u0392\u03b1\u03c3\u03af\u03bb\u03b5\u03b9\u03bf, \u03c0\u03c4\u03c5\u03c7\u03af\u03bf: \u201cPhysiology and Biochemistry\u201d, B.Sc. Hons.
\n1978-1982: \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03ae\u03bc\u03b9\u03bf \u03c4\u03b7\u03c2 O\u03be\u03c6\u03cc\u03c1\u03b4\u03b7\u03c2 (University of Oxford), \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03bf \u0392\u03b1\u03c3\u03af\u03bb\u03b5\u03b9\u03bf, \u0394\u03b9\u03b4\u03b1\u03ba\u03c4\u03bf\u03c1\u03b9\u03ba\u03ae \u03b4\u03b9\u03b1\u03c4\u03c1\u03b9\u03b2\u03ae (Doctor of Philosophy, D.Phil. Oxon), \u03bc\u03b5 \u03b8\u03ad\u03bc\u03b1 \u00abB\u03b9\u03bf\u03c3\u03cd\u03bd\u03b8\u03b5\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03b1\u03b9\u03bc\u03bf\u03c3\u03c6\u03b1\u03b9\u03c1\u03af\u03bd\u03b7\u03c2 E\u00bb (The synthesis of Haemoglobin E), \u03bc\u03b5 \u03b2\u03b1\u03b8\u03bc\u03cc “\u0386\u03c1\u03b9\u03c3\u03c4\u03b1”.<\/p>\n
\n1990-1996: \u039a\u03ac\u03b8\u03b5 \u03c7\u03c1\u03cc\u03bd\u03bf \u03ad\u03bd\u03b1 \u03bc\u03ae\u03bd\u03b1 \u03ae \u03c3\u03c4\u03bf \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03ae\u03bc\u03b9\u03bf \u03c4\u03b7\u03c2 O\u03be\u03c6\u03cc\u03c1\u03b4\u03b7\u03c2 \u03ae \u03c3\u03c4\u03bf University College London Medical School.<\/p>\n
\n2019-\u03c3\u03ae\u03bc\u03b5\u03c1\u03b1 \u0394\u03b9\u03b5\u03c5\u03b8\u03cd\u03bd\u03c4\u03c1\u03b9\u03b1 \u0395\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf\u03c5 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2, \u0395\u03b8\u03bd\u03b9\u03ba\u03cc \u03ba\u03b1\u03b9 \u039a\u03b1\u03c0\u03bf\u03b4\u03b9\u03c3\u03c4\u03c1\u03b9\u03b1\u03ba\u03cc \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03ae\u03bc\u03b9\u03bf \u0391\u03b8\u03b7\u03bd\u03ce\u03bd
\n2108-\u03c3\u03ae\u03bc\u03b5\u03c1\u03b1 \u039a\u03b1\u03b8\u03b7\u03b3\u03ae\u03c4\u03c1\u03b9\u03b1 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2, \u0395\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2, \u0395\u03b8\u03bd\u03b9\u03ba\u03cc \u03ba\u03b1\u03b9 \u039a\u03b1\u03c0\u03bf\u03b4\u03b9\u03c3\u03c4\u03c1\u03b9\u03b1\u03ba\u03cc \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03ae\u03bc\u03b9\u03bf \u0391\u03b8\u03b7\u03bd\u03ce\u03bd
\n2013-2018 \u0391\u03bd\u03b1\u03c0\u03bb\u03b7\u03c1\u03ce\u03c4\u03c1\u03b9\u03b1 \u039a\u03b1\u03b8\u03b7\u03b3\u03ae\u03c4\u03c1\u03b9\u03b1 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2, \u0395\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2, \u0395\u03b8\u03bd\u03b9\u03ba\u03cc \u03ba\u03b1\u03b9 \u039a\u03b1\u03c0\u03bf\u03b4\u03b9\u03c3\u03c4\u03c1\u03b9\u03b1\u03ba\u03cc \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03ae\u03bc\u03b9\u03bf \u0391\u03b8\u03b7\u03bd\u03ce\u03bd
\n2005-2012 \u0395\u03c0\u03af\u03ba\u03bf\u03c5\u03c1\u03b7 \u039a\u03b1\u03b8\u03b7\u03b3\u03ae\u03c4\u03c1\u03b9\u03b1 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2, \u0395\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2, \u0395\u03b8\u03bd\u03b9\u03ba\u03cc \u03ba\u03b1\u03b9 \u039a\u03b1\u03c0\u03bf\u03b4\u03b9\u03c3\u03c4\u03c1\u03b9\u03b1\u03ba\u03cc \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03ae\u03bc\u03b9\u03bf \u0391\u03b8\u03b7\u03bd\u03ce\u03bd
\n1986-2005 \u0392\u03b9\u03bf\u03bb\u03cc\u03b3\u03bf\u03c2 \u03c4\u03bf\u03c5 \u0395\u03a3\u03a5 \u03c3\u03c4\u03b7\u03bd A\u2019 \u03a0\u03b1\u03b9\u03b4\u03b9\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae K\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae \u03ba\u03b1\u03b9 \u03c3\u03c4\u03bf \u0395\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2, \u0395\u03b8\u03bd\u03b9\u03ba\u03cc \u03ba\u03b1\u03b9 \u039a\u03b1\u03c0\u03bf\u03b4\u03b9\u03c3\u03c4\u03c1\u03b9\u03b1\u03ba\u03cc \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03ae\u03bc\u03b9\u03bf \u0391\u03b8\u03b7\u03bd\u03ce\u03bd, X\u03c9\u03c1\u03ad\u03bc\u03b5\u03b9\u03bf E\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03b9\u03ba\u03cc E\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf, \u039d\u03bf\u03c3\u03bf\u03ba\u03bf\u03bc\u03b5\u03af\u03bf \u03a0\u03b1\u03af\u03b4\u03c9\u03bd \u00ab\u0397 \u0391\u03b3\u03b9\u03b1 \u03a3\u03bf\u03c6\u03af\u03b1\u00bb.
\n1984-1985 \u0395\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03bf\u03bd\u03b9\u03ba\u03cc\u03c2 \u03c3\u03c5\u03bd\u03b5\u03c1\u03b3\u03ac\u03c4\u03b7\u03c2 \u03c3\u03c4\u03b7\u03bd A\u2019 \u03a0\u03b1\u03b9\u03b4\u03b9\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae K\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae, \u0395\u03b8\u03bd\u03b9\u03ba\u03cc \u03ba\u03b1\u03b9 \u039a\u03b1\u03c0\u03bf\u03b4\u03b9\u03c3\u03c4\u03c1\u03b9\u03b1\u03ba\u03cc \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03ae\u03bc\u03b9\u03bf \u0391\u03b8\u03b7\u03bd\u03ce\u03bd, X\u03c9\u03c1\u03ad\u03bc\u03b5\u03b9\u03bf E\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03b9\u03ba\u03cc E\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf, \u039d\u03bf\u03c3\u03bf\u03ba\u03bf\u03bc\u03b5\u03af\u03bf \u03a0\u03b1\u03af\u03b4\u03c9\u03bd \u00ab\u0397 \u0391\u03b3\u03b9\u03b1 \u03a3\u03bf\u03c6\u03af\u03b1\u00bb, \u03bc\u03b5 \u03c5\u03c0\u03bf\u03c4\u03c1\u03bf\u03c6\u03af\u03b1 \u03b1\u03c0\u03cc \u03c4\u03bf E\u03b8\u03bd\u03b9\u03ba\u03cc \u038a\u03b4\u03c1\u03c5\u03bc\u03b1 E\u03c1\u03b5\u03c5\u03bd\u03ce\u03bd.<\/p>\n
\n\u0395\u03ba\u03c0\u03b1\u03b9\u03b4\u03b5\u03c5\u03c4\u03b9\u03ba\u03cc-\u0394\u03b9\u03b4\u03b1\u03ba\u03c4\u03b9\u03ba\u03cc \u03ad\u03c1\u03b3\u03bf \u03c3\u03b5 \u0391\u0395\u0399 \u03c3\u03c4\u03b7\u03bd \u0395\u03bb\u03bb\u03ac\u03b4\u03b1
\n\u0394\u03b9\u03b5\u03cd\u03b8\u03c5\u03bd\u03c4\u03b7 \u03c4\u03bf\u03c5 \u03a0\u03c1\u03bf\u03b3\u03c1\u03ac\u03bc\u03bc\u03b1\u03c4\u03bf\u03c2 \u039c\u03b5\u03c4\u03b1\u03c0\u03c4\u03c5\u03c7\u03b9\u03b1\u03ba\u03ce\u03bd \u03a3\u03c0\u03bf\u03c5\u03b4\u03ce\u03bd \u00ab\u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae: \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae & \u0395\u03c1\u03b3\u03b1\u03c3\u03c4\u03b7\u03c1\u03b9\u03b1\u03ba\u03ae \u039a\u03b1\u03c4\u03b5\u03cd\u03b8\u03c5\u03bd\u03c3\u03b7\u00bb (MSc in Medical Genetics: Clinical and Laboratory Direction).
\n\u03a0\u03b1\u03c1\u03b1\u03b4\u03af\u03b4\u03ce \u03bc\u03b1\u03b8\u03ae\u03bc\u03b1\u03c4\u03b1 \u03c3\u03b5 \u03c0\u03c1\u03bf\u03c0\u03c4\u03c5\u03c7\u03b9\u03b1\u03ba\u03cc \u03b5\u03c0\u03af\u03c0\u03b5\u03b4\u03bf, \u03b1\u03bb\u03bb\u03ac \u03ba\u03c5\u03c1\u03af\u03c9\u03c2 \u03c3\u03b5 \u03bc\u03b5\u03c4\u03b1\u03c0\u03c4\u03c5\u03c7\u03b9\u03b1\u03ba\u03cc \u03b5\u03c0\u03af\u03c0\u03b5\u03b4\u03bf, \u03c3\u03b5 8 \u03b4\u03b9\u03ac\u03c6\u03bf\u03c1\u03b5\u03c4\u03b9\u03ba\u03ac \u03c0\u03c1\u03bf\u03b3\u03c1\u03ac\u03bc\u03bc\u03b1\u03c4\u03b1 \u03c3\u03c0\u03bf\u03c5\u03b4\u03ce\u03bd \u03c4\u03bf\u03c5 \u0395\u039a\u03a0\u0391 (6 \u03c3\u03c4\u03b7\u03bd \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae \u03a3\u03c7\u03bf\u03bb\u03ae, \u03ba\u03b1\u03b9 2 \u03c3\u03c4\u03b7 \u03a3\u03c7\u03bf\u03bb\u03ae \u0398\u03b5\u03c4\u03b9\u03ba\u03ce\u03bd \u0395\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03ce\u03bd) \u03ba\u03b1\u03b8\u03ce\u03c2 \u03ba\u03b1\u03b9 \u03ad\u03bd\u03b1 \u03c3\u03c4\u03bf \u03a4\u03bc\u03ae\u03bc\u03b1 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u03c4\u03bf\u03c5 \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03af\u03bf\u03c5 \u0398\u03b5\u03c3\u03c3\u03b1\u03bb\u03af\u03b1\u03c2.
\n\u0395\u03ba\u03c0\u03b1\u03b9\u03b4\u03b5\u03c5\u03c4\u03b9\u03ba\u03cc-\u0394\u03b9\u03b4\u03b1\u03ba\u03c4\u03b9\u03ba\u03cc \u0388\u03c1\u03b3\u03bf \u03c3\u03b5 \u03b4\u03b9\u03b5\u03b8\u03bd\u03ae \u03c3\u03b5\u03bc\u03b9\u03bd\u03ac\u03c1\u03b9\u03b1
\n\u0388\u03c7\u03c9 \u03c0\u03ac\u03c1\u03b5\u03b9 \u03bc\u03ad\u03c1\u03bf\u03c2 \u03ce\u03c2 \u03bc\u03ad\u03bb\u03bf\u03c2 \u03c4\u03b7\u03c2 \u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03bf\u03bd\u03b9\u03ba\u03ae\u03c2 \u03ba\u03b1\u03b9 \u03bf\u03c1\u03b3\u03b1\u03bd\u03c9\u03c4\u03b9\u03ba\u03ae\u03c2 \u03b5\u03c0\u03b9\u03c4\u03c1\u03bf\u03c0\u03ae\u03c2, \u03ba\u03b1\u03b9 \u03c9\u03c2 \u03bf\u03bc\u03b9\u03bb\u03b7\u03c4\u03ae\u03c2 \u03c3\u03b5 >15 \u03c3\u03b5\u03bc\u03b9\u03bd\u03ac\u03c1\u03b9\u03b1, \u03c5\u03c0\u03cc \u03c4\u03b7\u03bd \u03b1\u03b9\u03b3\u03af\u03b4\u03b1 \u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03bf\u03bd\u03b9\u03ba\u03ce\u03bd \u03b5\u03c4\u03b1\u03b9\u03c1\u03b5\u03b9\u03ce\u03bd \u03cc\u03c0\u03c9\u03c2 \u03c4\u03bf \u0395uropean Molecular Genetics Quality Network (EMQN), \u03c4\u03bf European Society of Human Reproduction and Embryology, Eurogentest, \u03c4\u03bf European Society of Human Genetics \u03ba\u03b1\u03b9 \u03c4\u03bf Human Variome Project.<\/p>\n
\n\u03a3\u03c5\u03bc\u03bc\u03b5\u03c4\u03ad\u03c7\u03c9 (\u03ae \u03ad\u03c7\u03c9 \u03c3\u03c5\u03bc\u03bc\u03b5\u03c4\u03ac\u03c3\u03c7\u03b5\u03b9) \u03c3\u03b5 \u03c4\u03c1\u03b9\u03bc\u03b5\u03bb\u03b5\u03af\u03c2 \u03b5\u03c0\u03b9\u03c4\u03c1\u03bf\u03c0\u03ad\u03c2, \u03c9\u03c2 \u03b5\u03c0\u03b9\u03b2\u03bb\u03ad\u03c0\u03c9\u03bd \u03ba\u03b1\u03b9 \u03c3\u03b5 \u03b5\u03be\u03b5\u03c4\u03b1\u03c3\u03c4\u03b9\u03ba\u03ad\u03c2 \u03b5\u03c0\u03b9\u03c4\u03c1\u03bf\u03c0\u03ad\u03c2 \u03b3\u03b9\u03b1 \u03b4\u03b9\u03b4\u03b1\u03ba\u03c4\u03bf\u03c1\u03b9\u03ba\u03ad\u03c2 \u03ba\u03b1\u03b9 \u03b4\u03b9\u03c0\u03bb\u03c9\u03bc\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2 \u03b4\u03b9\u03b1\u03c4\u03c1\u03b9\u03b2\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03b5\u03ba\u03c4\u03b5\u03bb\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03c3\u03c4\u03bf \u0395\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2, \u03ac\u03bb\u03bb\u03c9\u03bd \u03a4\u03bc\u03b7\u03bc\u03ac\u03c4\u03c9\u03bd \u03c4\u03bf\u03c5 \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03af\u03bf\u03c5 \u0391\u03b8\u03b7\u03bd\u03ce\u03bd, \u03ac\u03bb\u03bb\u03c9\u03bd \u0391.\u0395.\u0399. \u03c4\u03b7\u03c2 \u0395\u03bb\u03bb\u03ac\u03b4\u03b1\u03c2 \u03ba\u03b1\u03b8\u03ce\u03c2 \u03ba\u03b1\u03b9 \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03ae\u03bc\u03b9\u03b1 \u03c4\u03bf\u03c5 \u0395\u03be\u03c9\u03c4\u03b5\u03c1\u03b9\u03ba\u03bf\u03cd. \u03a3\u03c5\u03b3\u03ba\u03b5\u03ba\u03c1\u03b9\u03bc\u03ad\u03bd\u03b1:
\n\u2022 \u0389\u03bc\u03bf\u03c5\u03bd \u03bc\u03ad\u03bb\u03bf\u03c2 \u03c4\u03b7\u03c2 \u03b5\u03be\u03b5\u03c4\u03b1\u03c3\u03c4\u03b9\u03ba\u03ae\u03c2 \u03b5\u03c0\u03b9\u03c4\u03c1\u03bf\u03c0\u03ae\u03c2 \u03c3\u03b5 19 \u0394\u03b9\u03b4\u03b1\u03ba\u03c4\u03bf\u03c1\u03b9\u03ba\u03ad\u03c2 \u03b4\u03b9\u03b1\u03c4\u03c1\u03b9\u03b2\u03ad\u03c2 (\u03bc\u03af\u03b1 \u03c9\u03c2 \u03b5\u03c0\u03b9\u03b2\u03bb\u03ad\u03c0\u03c9\u03bd) \u03c0\u03bf\u03c5 \u03ad\u03c7\u03bf\u03c5\u03bd \u03c0\u03b5\u03c1\u03b1\u03c4\u03c9\u03b8\u03b5\u03af \u03c3\u03c4\u03b7\u03bd \u0395\u03bb\u03bb\u03ac\u03b4\u03b1 \u03ba\u03b1\u03b9 5 \u03c3\u03c4\u03bf \u03b5\u03be\u03c9\u03c4\u03b5\u03c1\u03b9\u03ba\u03cc, \u03ba\u03b1\u03b9 \u03c3\u03c5\u03bc\u03bc\u03b5\u03c4\u03ad\u03c7\u03c9 \u03c3\u03b5 \u03ac\u03bb\u03bb\u03b5\u03c2 7 \u0394\u03b9\u03b4\u03b1\u03ba\u03c4\u03bf\u03c1\u03b9\u03ba\u03ad\u03c2 \u0394\u03b9\u03b1\u03c4\u03c1\u03b9\u03b2\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03b5\u03af\u03bd\u03b1\u03b9 \u03c3\u03b5 \u03b5\u03be\u03ad\u03bb\u03b9\u03be\u03b7 (3 \u03c9\u03c2 \u03b5\u03c0\u03b9\u03b2\u03bb\u03ad\u03c0\u03c9\u03bd).
\n\u2022 \u0395\u03b9\u03bc\u03b1\u03b9\/\u03ae\u03bc\u03bf\u03c5\u03bd \u03bc\u03ad\u03bb\u03bf\u03c2 \u03c4\u03b7\u03c2 \u03c4\u03c1\u03b9\u03bc\u03b5\u03bb\u03bf\u03cd\u03c2 \u03b5\u03c0\u03b9\u03c4\u03c1\u03bf\u03c0\u03ae\u03c2 \u03c3\u03b5 \u0394\u03b9\u03c0\u03bb\u03c9\u03bc\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2 \u0395\u03c1\u03b3\u03b1\u03c3\u03af\u03b5\u03c2, \u03c3\u03c4\u03b1 \u03c0\u03bb\u03b1\u03af\u03c3\u03b9\u03b1 \u03a0\u03c1\u03bf\u03c0\u03c4\u03c5\u03c7\u03b9\u03b1\u03ba\u03ce\u03bd \u03ba\u03b1\u03b9 \u039c\u03b5\u03c4\u03b1\u03c0\u03c4\u03c5\u03c7\u03b9\u03b1\u03ba\u03ce\u03bd \u03a0\u03c1\u03bf\u03b3\u03c1\u03b1\u03bc\u03bc\u03ac\u03c4\u03c9\u03bd (>40) \u03c4\u03bf\u03c5 \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03af\u03bf\u03c5 \u0391\u03b8\u03b7\u03bd\u03ce\u03bd \u03ba\u03b1\u03b9 \u03ac\u03bb\u03bb\u03c9\u03bd \u0391.\u0395.\u0399. \u03c4\u03b7\u03c2 \u0395\u03bb\u03bb\u03ac\u03b4\u03b1\u03c2.<\/p>\n
\n\u03a0\u03b5\u03c1\u03b9\u03b3\u03c1\u03b1\u03c6\u03ae \u03c4\u03bf\u03c5 \u03b5\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03b9\u03ba\u03bf\u03cd \u03ad\u03c1\u03b3\u03bf\u03c5 (\u03b1\u03c0\u03cc 1978- \u03c3\u03ae\u03bc\u03b5\u03c1\u03b1)
\n\u2022 \u039c\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c4\u03b7\u03c2 \u03bc\u03bf\u03c1\u03b9\u03b1\u03ba\u03ae\u03c2 \u03b3\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2 \u03c4\u03c9\u03bd \u03bc\u03b5\u03c3\u03bf\u03b3\u03b5\u03b9\u03b1\u03ba\u03ce\u03bd \u03c3\u03c5\u03bd\u03b4\u03c1\u03cc\u03bc\u03c9\u03bd (\u03b1\u03b9\u03bc\u03bf\u03c3\u03c6\u03b1\u03b9\u03c1\u03b9\u03bd\u03bf\u03c0\u03ac\u03b8\u03b5\u03b9\u03b5\u03c2)
\n\u2022 X\u03b1\u03c1\u03b1\u03ba\u03c4\u03b7\u03c1\u03b9\u03c3\u03bc\u03cc \u03c4\u03b7\u03c2 \u03bc\u03bf\u03c1\u03b9\u03b1\u03ba\u03ae\u03c2 \u03b3\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2 \u03c3\u03b5 \u03b4\u03b9\u03ac\u03c6\u03bf\u03c1\u03b1 \u03bc\u03bf\u03bd\u03bf\u03b3\u03bf\u03bd\u03b9\u03b4\u03b9\u03b1\u03ba\u03ac \u03bd\u03bf\u03c3\u03ae\u03bc\u03b1\u03c4\u03b1, \u03c3\u03c4\u03bf\u03bd \u0395\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03cc \u03c0\u03bb\u03b7\u03b8\u03c5\u03c3\u03bc\u03cc, \u03cc\u03c0\u03c9\u03c2: \u03a6\u03b1\u03b9\u03bd\u03c5\u03bb\u03bf\u03ba\u03b5\u03c4\u03bf\u03bd\u03bf\u03c5\u03c1\u03af\u03b1, \u039a\u03c5\u03c3\u03c4\u03b9\u03ba\u03ae \u038a\u03bd\u03c9\u03c3\u03b7, \u039f\u03b9\u03ba\u03bf\u03b3\u03b5\u03bd\u03ae\u03c2 \u03a5\u03c0\u03b5\u03c1\u03c7\u03bf\u03bb\u03b7\u03c3\u03c4\u03b5\u03c1\u03bf\u03bb\u03b1\u03b9\u03bc\u03af\u03b1, \u03c4\u03bf \u03c3\u03cd\u03bd\u03b4\u03c1\u03bf\u03bc\u03bf R\u0395\u03a4\u03a4, \u039d\u03b5\u03c6\u03c1\u03bf\u03c3\u03b9\u03ba\u03cc \u03a3\u03cd\u03bd\u03b4\u03c1\u03bf\u03bc\u03bf \u03c4\u03b7\u03c2 \u03c0\u03b1\u03b9\u03b4\u03b9\u03ba\u03ae\u03c2 \u03b7\u03bb\u03b9\u03ba\u03af\u03b1\u03c2, \u03ba\u03c1\u03b1\u03bd\u03b9\u03bf\u03c3\u03c5\u03bd\u03bf\u03c3\u03c4\u03ad\u03c9\u03c3\u03b7 \u03ba.\u03bb\u03c0.
\n\u2022 A\u03bd\u03ac\u03c0\u03c4\u03c5\u03be\u03b7 \u03ba\u03b1\u03b9 \u03b5\u03c0\u03b9\u03ba\u03cd\u03c1\u03c9\u03c3\u03b7 \u03bd\u03ad\u03c9\u03bd \u03c0\u03c1\u03c9\u03c4\u03bf\u03ba\u03cc\u03bb\u03bb\u03c9\u03bd \u03bc\u03bf\u03c1\u03b9\u03b1\u03ba\u03ae\u03c2 \u03b1\u03bd\u03ac\u03bb\u03c5\u03c3\u03b7\u03c2, \u03bc\u03b5 \u03c3\u03ba\u03bf\u03c0\u03cc \u03c4\u03b7\u03bd \u03b5\u03c6\u03b1\u03c1\u03bc\u03bf\u03b3\u03ae \u03c4\u03bf\u03c5\u03c2 \u03c3\u03b5 \u03b4\u03b9\u03b1\u03b3\u03bd\u03c9\u03c3\u03c4\u03b9\u03ba\u03ac \u03c0\u03c1\u03c9\u03c4\u03cc\u03ba\u03bf\u03bb\u03bb\u03b1, \u03b3\u03b9\u03b1 \u03c4\u03bf\u03bd \u03b3\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03cc \u03ad\u03bb\u03b5\u03b3\u03c7\u03bf \u03c6\u03bf\u03c1\u03ad\u03c9\u03bd, \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03ba\u03b1\u03b9 \u03b3\u03b9\u03b1 \u03c0\u03c1\u03bf\u03b3\u03b5\u03bd\u03bd\u03b7\u03c4\u03b9\u03ba\u03cc \u03ad\u03bb\u03b5\u03b3\u03c7\u03bf.
\n\u2022 \u03a0\u03c1\u03bf\u03c4\u03c5\u03c0\u03bf\u03c0\u03bf\u03af\u03b7\u03c3\u03b7 \u03ba\u03b1\u03b9 \u03b1\u03bd\u03ac\u03c0\u03c4\u03c5\u03be\u03b7 \u03bd\u03ad\u03c9\u03bd \u03bc\u03b5\u03b8\u03bf\u03b4\u03bf\u03bb\u03bf\u03b3\u03b9\u03ce\u03bd, \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03c0\u03c1\u03bf\u03b5\u03bc\u03c6\u03c5\u03c4\u03b5\u03c5\u03c4\u03b9\u03ba\u03ae \u03c0\u03c1\u03bf\u03b3\u03b5\u03bd\u03bd\u03b7\u03c4\u03b9\u03ba\u03ae \u03b4\u03b9\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7 (Preimplantation Genetic Diagnosis, PGD) \u03bc\u03bf\u03bd\u03bf\u03b3\u03bf\u03bd\u03b9\u03b4\u03b9\u03b1\u03ba\u03ce\u03bd \u03bd\u03bf\u03c3\u03b7\u03bc\u03ac\u03c4\u03c9\u03bd.
\n\u2022 \u03a0\u03c1\u03bf\u03c4\u03c5\u03c0\u03bf\u03c0\u03bf\u03af\u03b7\u03c3\u03b7 \u03ba\u03b1\u03b9 \u03b1\u03bd\u03ac\u03c0\u03c4\u03c5\u03be\u03b7 \u03bd\u03ad\u03c9\u03bd \u03bc\u03b5\u03b8\u03bf\u03b4\u03bf\u03bb\u03bf\u03b3\u03b9\u03ce\u03bd \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03bc\u03b7-\u0395\u03c0\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ae \u03a0\u03c1\u03bf\u03b3\u03b5\u03bd\u03bd\u03b7\u03c4\u03b9\u03ba\u03ae \u0394\u03b9\u03b1\u03b3\u03bd\u03c9\u03c3\u03c4\u03b9\u03ba\u03ae \u03b3\u03b9\u03b1 \u03c5\u03c0\u03bf\u03bb\u03b5\u03b9\u03c0\u03cc\u03bc\u03b5\u03bd\u03b1 \u03bc\u03bf\u03bd\u03bf\u03b3\u03bf\u03bd\u03b9\u03b4\u03b9\u03b1\u03ba\u03ac \u03bd\u03bf\u03c3\u03ae\u03bc\u03b1\u03c4\u03b1, \u03bc\u03b5 \u03bc\u03bf\u03bd\u03c4\u03ad\u03bb\u03bf \u03c4\u03b7\u03bd \u03b2-\u03bc\u03b5\u03c3\u03bf\u03b3\u03b5\u03b9\u03b1\u03ba\u03ae \u03b1\u03bd\u03b1\u03b9\u03bc\u03af\u03b1.
\n\u2022 \u0394\u03b9\u03b5\u03c1\u03b5\u03cd\u03bd\u03b7\u03c3\u03b7 \u03c4\u03c9\u03bd microRNAs \u03c3\u03b5 \u03b5\u03c1\u03c5\u03b8\u03c1\u03bf\u03ba\u03c5\u03c4\u03c4\u03b1\u03c1\u03b9\u03ba\u03ad\u03c2 \u03c3\u03b5\u03b9\u03c1\u03ad\u03c2 \u03b1\u03c0\u03cc \u03c6\u03c5\u03c3\u03b9\u03bf\u03bb\u03bf\u03b3\u03b9\u03ba\u03ac \u03ac\u03c4\u03bf\u03bc\u03b1 \u03ba\u03b1\u03b9 \u03c0\u03b5\u03c1\u03b9\u03c3\u03c4\u03b1\u03c4\u03b9\u03ba\u03ac \u03bc\u03b5 \u03b4\u03b9\u03ac\u03c6\u03bf\u03c1\u03b5\u03c2 \u03bc\u03bf\u03c1\u03c6\u03ad\u03c2 \u03bc\u03b5\u03c3\u03bf\u03b3\u03b5\u03b9\u03b1\u03ba\u03ae\u03c2 \u03b1\u03bd\u03b1\u03b9\u03bc\u03af\u03b1\u03c2.
\n\u2022 \u03a3\u03c5\u03c3\u03c7\u03ad\u03c4\u03b9\u03c3\u03b7 \u03bc\u03b7 \u03b5\u03c0\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ce\u03bd \u03b2\u03b9\u03bf\u03b4\u03b5\u03b9\u03ba\u03c4\u03ce\u03bd \u03bc\u03b5 \u03c4\u03b7\u03bd \u03c0\u03bf\u03b9\u03cc\u03c4\u03b7\u03c4\u03b1 \u03b1\u03bd\u03b8\u03c1\u03c9\u03c0\u03af\u03bd\u03c9\u03bd \u03c9\u03b1\u03c1\u03af\u03c9\u03bd \u03ba\u03b1\u03b9 \u03b5\u03bc\u03b2\u03c1\u03cd\u03c9\u03bd \u03c3\u03c4\u03b7\u03bd \u03c5\u03c0\u03bf\u03b2\u03bf\u03b7\u03b8\u03bf\u03cd\u03bc\u03b5\u03bd\u03b7 \u03b1\u03bd\u03b1\u03c0\u03b1\u03c1\u03b1\u03b3\u03c9\u03b3\u03ae.
\n\u2022 \u0397 \u03b1\u03be\u03b9\u03bf\u03bb\u03cc\u03b3\u03b7\u03c3\u03b7 \u03b4\u03b5\u03b4\u03bf\u03bc\u03ad\u03bd\u03c9\u03bd \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03b1\u03bb\u03bb\u03b7\u03bb\u03bf\u03cd\u03c7\u03b9\u03c3\u03b7 \u03b5\u03c0\u03cc\u03bc\u03b5\u03bd\u03b7\u03c2 \u03b3\u03b5\u03bd\u03b9\u03ac\u03c2 (Next Generation Sequencing, NGS) \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03c3\u03c0\u03ac\u03bd\u03b9\u03b5\u03c2 \u03b1\u03c3\u03b8\u03ad\u03bd\u03b5\u03b9\u03b5\u03c2 \u03ba\u03b1\u03b9 \u03b7 \u03b5\u03c0\u03b9\u03ba\u03cd\u03c1\u03c9\u03c3\u03b7 \u03bd\u03ad\u03c9\u03bd \u03c0\u03b1\u03c1\u03b1\u03bb\u03bb\u03b1\u03b3\u03ce\u03bd \u03c3\u03b5 \u03c3\u03c7\u03ad\u03c3\u03b7 \u03bc\u03b5 \u03c4\u03b7\u03bd \u03c0\u03b1\u03b8\u03bf\u03b3\u03ad\u03bd\u03b5\u03b9\u03b1.<\/p>\n
\n\u03a4\u03bf \u03c3\u03c5\u03b3\u03b3\u03c1\u03b1\u03c6\u03b9\u03ba\u03cc \u03bc\u03bf\u03c5 \u03ad\u03c1\u03b3\u03bf \u03b5\u03af\u03bd\u03b1\u03b9 \u03c0\u03bb\u03bf\u03cd\u03c3\u03b9\u03bf \u03ba\u03b1\u03b9 \u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03b5\u03b9 \u03c0\u03b5\u03c1\u03b9\u03c3\u03c3\u03cc\u03c4\u03b5\u03c1\u03b5\u03c2 \u03b1\u03c0\u03cc 155 \u03c0\u03c1\u03c9\u03c4\u03cc\u03c4\u03c5\u03c0\u03b5\u03c2 \u03b4\u03b7\u03bc\u03bf\u03c3\u03b9\u03b5\u03cd\u03c3\u03b5\u03b9\u03c2 \u03c3\u03b5 \u03be\u03b5\u03bd\u03cc\u03b3\u03bb\u03c9\u03c3\u03c3\u03b1 \u03c0\u03b5\u03c1\u03b9\u03bf\u03b4\u03b9\u03ba\u03ac (Peer reviewed \u2013 (\u03cc\u03c0\u03c9\u03c2 Nature, Lancet, J Clin Invest, Nature Genetics, American J Hum Genet, European J Human Genet, Hum Mutat, Hum Reprod). \u0395\u03c0\u03b9\u03c0\u03bb\u03ad\u03bf\u03bd, \u03c4\u03bf \u03c3\u03c5\u03b3\u03b3\u03c1\u03b1\u03c6\u03b9\u03ba\u03cc \u03bc\u03bf\u03c5 \u03ad\u03c1\u03b3\u03bf \u03ad\u03c7\u03b5\u03b9 \u03c0\u03b5\u03c1\u03b9\u03c3\u03c3\u03cc\u03c4\u03b5\u03c1\u03b5\u03c2 \u03b1\u03c0\u03cc 4450 \u03b2\u03b9\u03b2\u03bb\u03b9\u03bf\u03b3\u03c1\u03b1\u03c6\u03b9\u03ba\u03ad\u03c2 \u03b1\u03bd\u03b1\u03c6\u03bf\u03c1\u03ad\u03c2 \u03bc\u03b5 \u0397- \u0399ndex 38 (\u03b2\u03ac\u03c3\u03b5\u03b9 \u03c4\u03bf\u03c5 Scopus) \u03ae 6694 \u03b2\u03b9\u03b2\u03bb\u03b9\u03bf\u03b3\u03c1\u03b1\u03c6\u03b9\u03ba\u03ad\u03c2 \u03b1\u03bd\u03b1\u03c6\u03bf\u03c1\u03ad\u03c2 \u03c3\u03cd\u03bc\u03c6\u03c9\u03bd\u03b1 \u03bc\u03b5 \u0397-\u0399ndex 65 (\u03b2\u03ac\u03c3\u03b5\u03b9 \u03c4\u03bf\u03c5 Google Scholar). O\u03b9 \u03b4\u03b7\u03bc\u03bf\u03c3\u03b9\u03b5\u03cd\u03c3\u03b5\u03b9\u03c2 \u03ad\u03c7\u03bf\u03c5\u03bd \u03c3\u03c5\u03bd\u03bf\u03bb\u03b9\u03ba\u03cc Impact Factor (IF) 604.458, \u03bc\u03b5 \u03bc\u03ad\u03c3\u03bf\u03c2 \u03cc\u03c1\u03bf\u03c2 4.256.
\n\u0388\u03c7\u03c9 \u03b5\u03c0\u03af\u03c3\u03b7\u03c2 \u03b5\u03c0\u03b9\u03bc\u03b5\u03bb\u03b7\u03b8\u03b5\u03af \u03c4\u03b7\u03bd \u03ad\u03ba\u03b4\u03bf\u03c3\u03b7 2 \u03be\u03b5\u03bd\u03cc\u03b3\u03bb\u03c9\u03c3\u03c3\u03c9\u03bd \u03b2\u03b9\u03b2\u03bb\u03af\u03c9\u03bd \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2, \u03ad\u03c7\u03c9 \u03c3\u03c5\u03b3\u03b3\u03c1\u03ac\u03c8\u03b5\u03b9 8 \u03ba\u03b5\u03c6\u03ac\u03bb\u03b1\u03b9\u03b1 \u03c3\u03b5 \u03be\u03b5\u03bd\u03cc\u03b3\u03bb\u03c9\u03c3\u03c3\u03b1 \u03b2\u03b9\u03b2\u03bb\u03af\u03b1 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2 \u03ba\u03b1\u03b9 \u03ac\u03bb\u03bb\u03b1 \u03c4\u03cc\u03c3\u03b1 \u03c3\u03b5 \u03b5\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ac \u03b2\u03b9\u03b2\u03bb\u03af\u03b1 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2.
\n\u0388\u03c7\u03c9 \u03c0\u03b5\u03c1\u03b9\u03c3\u03c3\u03cc\u03c4\u03b5\u03c1\u03b5\u03c2 \u03b1\u03c0\u03cc 10 \u03c0\u03c1\u03c9\u03c4\u03cc\u03c4\u03c5\u03c0\u03b5\u03c2 \u03b4\u03b7\u03bc\u03bf\u03c3\u03b9\u03b5\u03cd\u03c3\u03b5\u03b9\u03c2 \u03c3\u03c4\u03bf\u03bd \u03b5\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03cc \u03b9\u03b1\u03c4\u03c1\u03b9\u03ba\u03cc \u03c4\u03cd\u03c0\u03bf, \u03ba\u03b1\u03b8\u03ce\u03c2 \u03ba\u03b1\u03b9 10 \u03ba\u03b5\u03c6\u03ac\u03bb\u03b1\u03b9\u03b1 \u03c3\u03b5 \u03b2\u03b9\u03b2\u03bb\u03af\u03b1.<\/p>\n
\n1990-1992: \u00ab\u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03cc\u03c2 \u03c7\u03b1\u03c1\u03b1\u03ba\u03c4\u03b7\u03c1\u03b9\u03c3\u03bc\u03cc\u03c2 \u03ba\u03b1\u03b9 \u03c3\u03c5\u03c7\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 \u03bc\u03bf\u03c1\u03b9\u03b1\u03ba\u03ce\u03bd \u03b2\u03bb\u03b1\u03b2\u03ce\u03bd \u03c3\u03b5 \u03b1\u03c1\u03c1\u03ce\u03c3\u03c4\u03bf\u03c5\u03c2 \u03bc\u03b5 \u03b2-\u03bc\u03b5\u03c3\u03bf\u03b3\u03b5\u03b9\u03b1\u03ba\u03ae \u03b1\u03bd\u03b1\u03b9\u03bc\u03af\u03b1 \u03c3\u03c4\u03b7\u03bd \u0395\u03bb\u03bb\u03ac\u03b4\u03b1\u00bb.
\n1990-1994: \u201cThalassemia Intermedia Syndromes: Molecular, Hematological, Clinical and Therapeutic Studies\u201d \u03c3\u03c4\u03bf \u03a0\u03c1\u03cc\u03b3\u03c1\u03b1\u03bc\u03bc\u03b1: Life Sciences and Technologies for developing Countries (STD3).
\n2002-2005: \u00ab\u0391\u03bd\u03ac\u03c0\u03c4\u03c5\u03be\u03b7 \u03bc\u03b9\u03ba\u03c1\u03bf\u03c3\u03c5\u03c3\u03c4\u03bf\u03b9\u03c7\u03af\u03c9\u03bd DNA \u03b3\u03b9\u03b1 \u03b4\u03b9\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03ba\u03c5\u03c3\u03c4\u03b9\u03ba\u03ae\u03c2 \u03b9\u03bd\u03ce\u03b4\u03bf\u03c5\u03c2 \u03bd\u03cc\u03c3\u03bf\u03c5\u00bb. (Novel genechip technology for simplified detection of molecularly heterogeneous genetic diseases: Detection of cystic fibrosis as a model. Acronym: CF-CHIP, \u03b1\u03c1\u03b9\u03b8\u03bc\u03cc \u03c3\u03cd\u03bc\u03b2\u03b1\u03c3\u03b7\u03c2 QLRT3-CT-2001- 01982), \u03c3\u03c4\u03bf 5\u03bf \u03c0\u03c1\u03cc\u03b3\u03c1\u03b1\u03bc\u03bc\u03b1 \u03c3\u03c4\u03ae\u03c1\u03b9\u03be\u03b7\u03c2 \u03c4\u03b7\u03c2 E\u03c5\u03c1\u03c9\u03c0\u03b1\u03ca\u03ba\u03ae\u03c2 \u0395\u03bd\u03ce\u03c3\u03b5\u03c9\u03c2, (EU Fifth Framework, Quality of Life Programme). \u03a3\u03c5\u03bd\u03bf\u03bb\u03b9\u03ba\u03cc\u03c2 \u03c0\u03c1\u03bf\u03cb\u03c0\u03bf\u03bb\u03bf\u03b3\u03b9\u03c3\u03bc\u03cc\u03c2 \u20ac1,633,300, \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03bf\u03bc\u03ac\u03b4\u03b1 \u03bc\u03b1\u03c2 \u20ac150,000 .
\n2006-2007: \u00ab\u039c\u03bf\u03c1\u03b9\u03b1\u03ba\u03ae \u03b1\u03bd\u03ac\u03bb\u03c5\u03c3\u03b7 \u03bc\u03b5\u03c4\u03b1\u03bb\u03bb\u03ac\u03be\u03b5\u03c9\u03bd \u03ba\u03b1\u03b9 \u03c0\u03bf\u03bb\u03c5\u03bc\u03bf\u03c1\u03c6\u03b9\u03c3\u03bc\u03ce\u03bd \u03c3\u03c4\u03bf \u03b3\u03bf\u03bd\u03af\u03b4\u03b9\u03bf NHPS2 \u03c4\u03b7\u03c2 \u03c0\u03bf\u03b4\u03bf\u03ba\u03af\u03bd\u03b7\u03c2 \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03bd\u03b5\u03c6\u03c1\u03bf\u03c3\u03b9\u03ba\u03cc \u03c3\u03cd\u03bd\u03b4\u03c1\u03bf\u03bc\u03bf \u03b1\u03bd\u03b8\u03b5\u03ba\u03c4\u03b9\u03ba\u03bf\u03cd\u03c2 \u03c3\u03c4\u03b7 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03bc\u03b5 \u03ba\u03bf\u03c1\u03c4\u03b9\u03ba\u03bf\u03b5\u03b9\u03b4\u03ae\u00bb. (\u039a\u03cd\u03c1\u03b9\u03bf\u03c2 \u03b5\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03ae\u03c2).
\n2006-2008: \u201ce-Infrastructure for Thalassemia\u201d (Acronym:ITHANET, \u03b1\u03c1\u03b9\u03b8\u03bc\u03cc\u03c2 \u03c3\u03cd\u03bc\u03b2\u03b1\u03c3\u03b7\u03c2. 026539), \u03c3\u03c4\u03bf 6\u03bf \u03c0\u03c1\u03cc\u03b3\u03c1\u03b1\u03bc\u03bc\u03b1 \u03c3\u03c4\u03ae\u03c1\u03b9\u03be\u03b7\u03c2 \u03c4\u03b7\u03c2 E\u03c5\u03c1\u03c9\u03c0\u03b1\u03ca\u03ba\u03ae\u03c2 \u0395\u03bd\u03ce\u03c3\u03b5\u03c9\u03c2, (EU Sixth Framework, Research Infrastructures-Communication Networks Development). \u03a3\u03c5\u03bb\u03bf\u03bb\u03b9\u03ba\u03cc\u03c2 \u03c0\u03c1\u03bf\u03cb\u03c0\u03bf\u03bb\u03bf\u03b3\u03b9\u03c3\u03bc\u03cc\u03c2
\n\u20ac1,200,000, \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03bf\u03bc\u03ac\u03b4\u03b1 \u03bc\u03b1\u03c2 \u20ac44,000.
\n2012: John S. Latsis Public Benefit Foundation award. Project title \u201cmicroRNAs studies in normal and thalassaemic human erythroid progenitors to investigate modifiers of globin expression and potential therapeutic pathways for thalassaemia syndromes\u201d. (\u039a\u03cd\u03c1\u03b9\u03bf\u03c2 \u03b5\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03ae\u03c2). (\u20ac12,000).
\n2012-2017: European Society of Human Reproduction and Embryology (ESHRE) funded project entitled \u201cThe ESHRE Study into the evaluation of oocyte euploidy by microarray analysis (ESTEEM) trial\u201d. See Clinicaltrials.gov, Trial number NCT01532284 (\u039a\u03cd\u03c1\u03b9\u03bf\u03c2 \u03b5\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03ae\u03c2 \u03b3\u03b9\u03b1 \u03c4\u03bf \u0395\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2).
\n2013-2015: \u201c3Gb test: Introducing diagnostic applications of \u20183Gb-testing\u2019 in human genetics\u201d \u03c3\u03c4\u03bf 7\u03bf \u03c0\u03c1\u03cc\u03b3\u03c1\u03b1\u03bc\u03bc\u03b1 \u03c3\u03c4\u03ae\u03c1\u03b9\u03be\u03b7\u03c2 \u03c4\u03b7\u03c2 E\u03c5\u03c1\u03c9\u03c0\u03b1\u03ca\u03ba\u03ae\u03c2 \u0395\u03bd\u03ce\u03c3\u03b5\u03c9\u03c2 (\u03b1\u03c1\u03b9\u03b8\u03bc\u03cc\u03c2 \u03c3\u03cd\u03bc\u03b2\u03b1\u03c3\u03b7\u03c2. 602269). \u03a3\u03c5\u03bb\u03bf\u03bb\u03b9\u03ba\u03cc\u03c2 \u03c0\u03c1\u03bf\u03cb\u03c0\u03bf\u03bb\u03bf\u03b3\u03b9\u03c3\u03bc\u03cc\u03c2 \u20ac500,000, \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03bf\u03bc\u03ac\u03b4\u03b1 \u03bc\u03b1\u03c2 \u20ac44,000). (\u039a\u03cd\u03c1\u03b9\u03bf\u03c2 \u03b5\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03ae\u03c2 \u03b3\u03b9\u03b1 \u03c4\u03bf \u0395\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2)
\n2018: \u201c\u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae \u0391\u03c0\u03bf\u03c4\u03cd\u03c0\u03c9\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03a4\u03b1\u03c5\u03c4\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03c9\u03bd \u0395\u03c1\u03c5\u03b8\u03c1\u03bf\u03ba\u03c5\u03c4\u03c4\u03ac\u03c1\u03c9\u03bd \u03ba\u03b1\u03b9 \u03c4\u03c9\u03bd \u0394\u03b9\u03b1\u03c4\u03b1\u03c1\u03b1\u03c7\u03ce\u03bd \u03c4\u03b7\u03c2 \u0395\u03c1\u03c5\u03b8\u03c1\u03bf\u03c0\u03bf\u03af\u03b7\u03c3\u03b7\u03c2\u00bb\u201d \u039a\u03a9\u0394\u0399\u039a\u039f: 01224, \u0391\u039a\u03a1\u03a9\u039d\u03a5\u039c\u0399\u039f: REDNGS \u0394\u03c1\u03ac\u03c3\u03b7\u03c2 \u00ab\u0395\u03a1\u0395\u03a5\u039d\u03a9 \u2013 \u0394\u0397\u039c\u0399\u039f\u03a5\u03a1\u0393\u03a9 –
\n\u039a\u0391\u0399\u039d\u039f\u03a4\u039f\u039c\u03a9\u00bb (\u0395\u03a3\u03a0\u0391 2014-2020). \u03a3\u03c5\u03bd\u03bf\u03bb\u03b9\u03ba\u03cc\u03c2 \u03c0\u03c1\u03bf\u03cb\u03c0\u03bf\u03bb\u03bf\u03b3\u03b9\u03c3\u03bc\u03cc\u03c2 \u20ac1,000,000. \u0393\u03b9\u03b1 \u03c4\u03bf \u0395\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2 \u20ac120,000. (\u039a\u03cd\u03c1\u03b9\u03bf\u03c2 \u03b5\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03ae\u03c2 \u03b3\u03b9\u03b1 \u03c4\u03bf \u0395\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2).<\/p>\n
\n\u0397 \u03b5\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03b9\u03ba\u03ae \u03c4\u03b7\u03c2 \u03b4\u03c1\u03b1\u03c3\u03c4\u03b7\u03c1\u03b9\u03cc\u03c4\u03b7\u03c4\u03b1 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03c2 \u03bf\u03bc\u03ac\u03b4\u03b1\u03c2 \u03c4\u03b7\u03c2 \u03b3\u03b5\u03bd\u03b9\u03ba\u03cc\u03c4\u03b5\u03c1\u03b1, \u03ad\u03c7\u03b5\u03b9 \u03b2\u03c1\u03b1\u03b2\u03b5\u03c5\u03b8\u03b5\u03af \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u0395\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ae \u0391\u03b9\u03bc\u03b1\u03c4\u03bf\u03bb\u03bf\u03b3\u03b9\u03ba\u03ae \u0395\u03c4\u03b1\u03b9\u03c1\u03b5\u03af\u03b1 (1997, 1998, 2011), \u03c4\u03b7\u03bd \u0395\u03c4\u03b1\u03b9\u03c1\u03b5\u03af\u03b1 \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae\u03c2 \u03a7\u03b7\u03bc\u03b5\u03af\u03b1\u03c2 (1998), o\u03c4 4th International Congress \u2013The young Woman at the Rise of 21st Century (1998), \u03c4\u03b7\u03bd \u0395\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ae \u03a0\u03b1\u03b9\u03b4\u03b9\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae \u0395\u03c4\u03b1\u03b9\u03c1\u03b5\u03af\u03b1 (\u03a7\u03c9\u03c1\u03ad\u03bc\u03b5\u03b9\u03bf \u0388\u03c0\u03b1\u03b8\u03bb\u03bf-1986, 1987, 1991, 1992, 1993, 1994, 1995, 1996, 1997,
\n1998, 1999, 2000, 2001, 2007, 2009), \u03c4\u03b7\u03bd \u0395\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ae \u0395\u03c4\u03b1\u03b9\u03c1\u03b5\u03af\u03b1 \u03a0\u03b1\u03b9\u03b4\u03b9\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u0391\u03b9\u03bc\u03b1\u03c4\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2- \u039f\u03b3\u03ba\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2 (2010), \u03c4\u03bf \u00abRoyal College of Obstetrics and Gynaecology\u00bb (2011).<\/p>\n
\n1. \u03a3\u03cd\u03bd\u03b4\u03b5\u03c3\u03bc\u03bf\u03c2 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ce\u03bd \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03c3\u03c4\u03ce\u03bd \u0395\u03bb\u03bb\u03ac\u03b4\u03b1\u03c2 (\u03a3I\u0393E).
\n2. European Society of Human Genetics (ESHG).
\n3. European Society for Human Reproduction and Embryology (ESHRE).<\/p>\n
\nM\u03ad\u03bb\u03bf\u03c2 \u03c4\u03b7\u03c2 \u03c3\u03c5\u03bd\u03c4\u03b1\u03ba\u03c4\u03b9\u03ba\u03ae\u03c2 \u03b5\u03c0\u03b9\u03c4\u03c1\u03bf\u03c0\u03ae\u03c2 (\u03b1\u03c0\u03cc 1998 \u03ad\u03c9\u03c2 \u03c3\u03ae\u03bc\u03b5\u03c1\u03b1) \u03c4\u03bf\u03c5 \u03c0\u03b5\u03c1\u03b9\u03bf\u03b4\u03b9\u03ba\u03bf\u03cd \u201dHemoglobin Journal\u201d (Taylor and Francis) \u03ba\u03b1\u03b9 \u0391\u03bd\u03b1\u03c0\u03bb\u03b7\u03c1\u03c9\u03c4\u03ae\u03c2 \u03a3\u03c5\u03bd\u03c4\u03ac\u03ba\u03c4\u03b7\u03c2 \u03b1\u03c0\u03cc 1.1.2003 \u03bc\u03ad\u03c7\u03c1\u03b9 \u03c3\u03ae\u03bc\u03b5\u03c1\u03b1.
\nM\u03ad\u03bb\u03bf\u03c2 \u03c4\u03b7\u03c2 \u03c3\u03c5\u03bd\u03c4\u03b1\u03ba\u03c4\u03b9\u03ba\u03ae\u03c2 \u03b5\u03c0\u03b9\u03c4\u03c1\u03bf\u03c0\u03ae\u03c2 (\u03b1\u03c0\u03cc 2016 \u03ad\u03c9\u03c2 \u03c3\u03ae\u03bc\u03b5\u03c1\u03b1) \u03c4\u03bf\u03c5 \u03c0\u03b5\u03c1\u03b9\u03bf\u03b4\u03b9\u03ba\u03bf\u03cd \u039f\u0392\u039c Genetics (Open BioMedical \u03c3\u03b5\u03b9\u03c1\u03ac \u03c0\u03b5\u03c1\u03b9\u03bf\u03b4\u03b9\u03ba\u03ce\u03bd).
\n\u039a\u03c1\u03b9\u03c4\u03ae\u03c2 \u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03bf\u03bd\u03b9\u03ba\u03ce\u03bd \u03ac\u03c1\u03b8\u03c1\u03c9\u03bd \u03c3\u03b5 >20 \u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03bf\u03bd\u03b9\u03ba\u03ac \u03c0\u03b5\u03c1\u03b9\u03bf\u03b4\u03b9\u03ba\u03ac \u03bc\u03b5 > 10-15 \u03ac\u03c1\u03b8\u03c1\u03b1 \u03b5\u03c4\u03b7\u03c3\u03af\u03c9\u03c2.<\/p>\n
\n\u03a0\u03c1\u03bf\u03c3\u03ba\u03b5\u03ba\u03bb\u03b7\u03bc\u03ad\u03bd\u03b5\u03c2 \u03be\u03b5\u03bd\u03cc\u03b3\u03bb\u03c9\u03c3\u03c3\u03b5\u03c2 \u03b5\u03b9\u03c3\u03b7\u03b3\u03ae\u03c3\u03b5\u03b9\u03c2\/\u03b4\u03b9\u03b1\u03bb\u03ad\u03be\u03b5\u03b9\u03c2 \u03c3\u03b5 \u03b4\u03b9\u03b5\u03b8\u03bd\u03b5\u03af\u03c2 \u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03bf\u03bd\u03b9\u03ba\u03ad\u03c2 \u03c3\u03c5\u03bd\u03b1\u03bd\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2 \u03c3\u03b5 \u03cc\u03bb\u03bf\u03bd \u03c4\u03bf\u03bd \u03ba\u03cc\u03c3\u03bc\u03bf: >50
\n\u0395\u03b9\u03c3\u03b7\u03b3\u03ae\u03c3\u03b5\u03b9\u03c2 \u03c3\u03c4\u03b7\u03bd \u0395\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ae: >25
\n\u039e\u03b5\u03bd\u03cc\u03b3\u03bb\u03c9\u03c3\u03c3\u03b5\u03c2 \u03b1\u03bd\u03b1\u03ba\u03bf\u03b9\u03bd\u03ce\u03c3\u03b5\u03b9\u03c2 \u03c3\u03b5 \u03b4\u03b9\u03b5\u03b8\u03bd\u03b5\u03af\u03c2 \u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03bf\u03bd\u03b9\u03ba\u03ad\u03c2 \u03c3\u03c5\u03bd\u03b1\u03bd\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2: > 120
\nA\u03bd\u03b1\u03ba\u03bf\u03b9\u03bd\u03ce\u03c3\u03b5\u03b9\u03c2 \u03c3\u03c4\u03b7\u03bd \u0395\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ae: > 105<\/p>\n
\n\u039c\u03ad\u03bb\u03bf\u03c2 \u03c4\u03bf\u03c5 \u0394.\u03a3. (\u03b1\u03c0\u03cc \u03c4\u03bf 2004-2010) \u03c4\u03b7\u03c2 \u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03bf\u03bd\u03b9\u03ba\u03ae\u03c2 \u03b5\u03c4\u03b1\u03b9\u03c1\u03b5\u03af\u03b1\u03c2 \u00abEuropean Society of Human Reproduction and Embryology\u00bb (ESHRE), Consortium for Preimplantation Genetic Diagnosis (PGD). \u0391\u03bd\u03c4\u03b9\u03c0\u03c1\u03cc\u03b5\u03b4\u03c1\u03bf\u03c2 \u03c4\u03bf\u03c5 \u0394.\u03a3. (2010-2012) \u03c4\u03b7\u03c2 ESHRE, Consortium for Preimplantation Genetic Diagnosis (PGD).
\n\u03a0\u03c1\u03cc\u03b5\u03b4\u03c1\u03bf\u03c2 \u03c4\u03bf\u03c5 \u0394.\u03a3. (2104-2014) \u03c4\u03b7\u03c2 ESHRE Consortium for Preimplantation Genetic Diagnosis (PGD).
\n\u039c\u03ad\u03bb\u03bf\u03c2 \u03c4\u03bf\u03c5 \u0394.\u03a3. \u03c4\u03bf\u03c5 \u00ab\u03a3\u03c5\u03bd\u03b4\u03ad\u03c3\u03bc\u03bf\u03c5 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ce\u03bd \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03c3\u03c4\u03ce\u03bd \u0395\u03bb\u03bb\u03ac\u03b4\u03b1\u03c2\u00bb, 2004-2007.
\n\u039c\u03ad\u03bb\u03bf\u03c2 \u03c4\u03bf\u03c5 \u0394.\u03a3. (\u0391\u03bd\u03c4\u03b9\u03c0\u03bf\u03c1\u03cc\u03b5\u03b4\u03c1\u03bf\u03c2) \u03c4\u03bf\u03c5 \u00ab\u03a3\u03c5\u03bd\u03b4\u03ad\u03c3\u03bc\u03bf\u03c5 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ce\u03bd \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03c3\u03c4\u03ce\u03bd \u0395\u03bb\u03bb\u03ac\u03b4\u03b1\u03c2\u00bb, 2016- \u03c3\u03ae\u03bc\u03b5\u03c1\u03b1. \u039c\u03ad\u03bb\u03bf\u03c2 \u03c4\u03bf\u03c5 \u0394.\u03a3. (2008-2014) \u03ba\u03b1\u03b9 \u03bc\u03ad\u03bb\u03bf\u03c2 \u03c4\u03b7\u03c2 \u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03bf\u03bd\u03b9\u03ba\u03ae\u03c2 \u03b5\u03c0\u03b9\u03c4\u03c1\u03bf\u03c0\u03ae\u03c2 (\u03b1\u03c0\u03cc 2008 – 2016) \u03c4\u03b7\u03c2
\n\u00ab\u03a0\u03b1\u03bd\u03b5\u03bb\u03bb\u03ae\u03bd\u03b9\u03b1\u03c2 \u0388\u03bd\u03c9\u03c3\u03b7\u03c2 \u03a3\u03c0\u03b1\u03bd\u03af\u03c9\u03bd \u03a0\u03b1\u03b8\u03ae\u03c3\u03b5\u03c9\u03bd\u00bb.
\n\u0391\u03c0\u03cc \u03c4\u03bf 1986 \u03ad\u03c9\u03c2 \u03c3\u03ae\u03bc\u03b5\u03c1\u03b1 \u03c3\u03c5\u03bc\u03bc\u03b5\u03c4\u03ad\u03c7\u03c9 \u03c9\u03c2 \u03bc\u03ad\u03bb\u03bf\u03c2 \u03b5\u03c0\u03b9\u03c4\u03c1\u03bf\u03c0\u03ce\u03bd \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03c3\u03cd\u03bd\u03c4\u03b1\u03be\u03b7 \u03ba\u03b1\u03b9 \u03b1\u03be\u03b9\u03bf\u03bb\u03cc\u03b3\u03b7\u03c3\u03b7 \u03bf\u03c1\u03b3\u03ac\u03bd\u03c9\u03bd, \u03b1\u03bd\u03c4\u03b9\u03b4\u03c1\u03b1\u03c3\u03c4\u03b7\u03c1\u03af\u03c9\u03bd \u03ba\u03b1\u03b9 \u03b1\u03bd\u03b1\u03bb\u03c9\u03c3\u03af\u03bc\u03c9\u03bd \u03c5\u03bb\u03b9\u03ba\u03ce\u03bd \u03b3\u03b9\u03b1 \u03c4\u03b1 \u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03b1 \u03c4\u03bf\u03c5 \u039d\u03bf\u03c3\u03bf\u03ba\u03bf\u03bc\u03b5\u03af\u03bf\u03c5 \u03a0\u03b1\u03af\u03b4\u03c9\u03bd, \u0397 \u0391\u03b3\u03af\u03b1 \u03a3\u03bf\u03c6\u03af\u03b1\u00bb \u03ba\u03b1\u03b9 \u03c4\u03bf \u0395\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2.
\n\u0391\u03c0\u03cc \u03c4\u03bf 2008 \u03ad\u03c9\u03c2 \u03c3\u03ae\u03bc\u03b5\u03c1\u03b1 \u03c3\u03c5\u03bc\u03bc\u03b5\u03c4\u03ad\u03c7\u03c9 \u03c9\u03c2 \u03bc\u03ad\u03bb\u03bf\u03c2 \u03c4\u03b7\u03c2 \u03b5\u03c0\u03b9\u03c4\u03c1\u03bf\u03c0\u03ae\u03c2 \u03b3\u03b9\u03b1 \u03ad\u03bb\u03b5\u03b3\u03c7\u03bf \u03c0\u03bf\u03b9\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c3\u03c4\u03b7\u03bd \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae \u03b5\u03c6\u03b1\u03c1\u03bc\u03bf\u03b3\u03ae \u03c4\u03b7\u03c2 \u03a0\u03c1\u03bf\u03b5\u03bc\u03c6\u03c5\u03c4\u03b5\u03c5\u03c4\u03b9\u03ba\u03ae\u03c2 \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\u03c2 \u0394\u03b9\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7\u03c2 \u00abUK NEQAS\/CEQA Preimplantation Genetic Diagnosis EQA Specialist Advisory Group\u201d. (https:\/\/www.ukneqas-molgen.org.uk\/node\/145 ), \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03bf \u0392\u03b1\u03c3\u03af\u03bb\u03b5\u03b9\u03bf.
\n\u0391\u03c0\u03cc \u03c4\u03bf 2007 \u03ad\u03c9\u03c2 \u03c3\u03ae\u03bc\u03b5\u03c1\u03b1 \u03c3\u03c5\u03bc\u03bc\u03b5\u03c4\u03ad\u03c7\u03c9 \u03c9\u03c2 \u03bc\u03ad\u03bb\u03bf\u03c2 \u03c4\u03b7\u03c2 \u03b5\u03c0\u03b9\u03c4\u03c1\u03bf\u03c0\u03ae\u03c2 \u03b5\u03bc\u03c0\u03b5\u03b9\u03c1\u03bf\u03b3\u03bd\u03c9\u03bc\u03cc\u03bd\u03c9\u03bd, \u03b3\u03b9\u03b1 \u03b1\u03b9\u03bc\u03bf\u03c3\u03c6\u03b1\u03b9\u03c1\u03b9\u03bd\u03bf\u03c0\u03ac\u03b8\u03b9\u03b5\u03c2 (Haemoglobinopathy Expert Panel), \u03c0\u03bf\u03c5 \u03c5\u03c0\u03ac\u03b3\u03b5\u03c4\u03b1\u03b9 \u03c3\u03c4\u03bf ClinGen \u03ba\u03b1\u03b9 \u03c4\u03bf \u201cClinical Genome Research\u00bb \u03c3\u03c4\u03bf \u00abNational Human Genome Research Institute\u201d, \u0397\u03a0\u0391.<\/p>\n